1. Home
  2. GNTX vs GRFS Comparison

GNTX vs GRFS Comparison

Compare GNTX & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTX
  • GRFS
  • Stock Information
  • Founded
  • GNTX 1974
  • GRFS 1940
  • Country
  • GNTX United States
  • GRFS Spain
  • Employees
  • GNTX N/A
  • GRFS N/A
  • Industry
  • GNTX Auto Parts:O.E.M.
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GNTX Consumer Discretionary
  • GRFS Health Care
  • Exchange
  • GNTX Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • GNTX 6.1B
  • GRFS 7.2B
  • IPO Year
  • GNTX N/A
  • GRFS 2006
  • Fundamental
  • Price
  • GNTX $28.51
  • GRFS $9.83
  • Analyst Decision
  • GNTX Buy
  • GRFS Hold
  • Analyst Count
  • GNTX 7
  • GRFS 1
  • Target Price
  • GNTX $29.14
  • GRFS $10.30
  • AVG Volume (30 Days)
  • GNTX 1.7M
  • GRFS 526.8K
  • Earning Date
  • GNTX 10-24-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • GNTX 1.70%
  • GRFS 1.45%
  • EPS Growth
  • GNTX N/A
  • GRFS 132.60
  • EPS
  • GNTX 1.77
  • GRFS 0.53
  • Revenue
  • GNTX $2,384,794,644.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • GNTX $11.01
  • GRFS $6.00
  • Revenue Next Year
  • GNTX $6.50
  • GRFS $6.71
  • P/E Ratio
  • GNTX $15.94
  • GRFS $24.77
  • Revenue Growth
  • GNTX 2.43
  • GRFS 9.32
  • 52 Week Low
  • GNTX $20.28
  • GRFS $6.19
  • 52 Week High
  • GNTX $31.72
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • GNTX 61.35
  • GRFS 46.27
  • Support Level
  • GNTX $27.53
  • GRFS $9.63
  • Resistance Level
  • GNTX $28.64
  • GRFS $10.14
  • Average True Range (ATR)
  • GNTX 0.50
  • GRFS 0.19
  • MACD
  • GNTX -0.10
  • GRFS -0.02
  • Stochastic Oscillator
  • GNTX 78.95
  • GRFS 40.00

About GNTX Gentex Corporation

Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue is about 98% of total revenue. The company is constantly developing new applications for the technology to remain on top. Sales in 2024 totaled about $2.3 billion with 47.7 million mirrors shipped. The unit mix breaks out as 63% interior and 37% exterior, versus 31% exterior in 2019. The company is based in Zeeland, Michigan.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: